A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy

Phase 3 Completed 177 enrolled Jazz Pharmaceuticals

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to determine whether Sativex® and GW-2000-02 are effective in the management of subjects with intractable cancer-related pain.

Timeline

Start: 2002-02
Primary completion: 2004-02
Completion: 2004-03

Publications

Results Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010 Feb;39(2):167-79. doi: 10.1016/j.jpainsymman.2009.06.008. Epub 2009 Nov 5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	GW-2000-02	Unknown	27 mg/ml	Other
Subject	Nabiximols	Other / unclassified	25 mg/ml	Other
Subject	Nabiximols	Other / unclassified	27 mg/ml	Other

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy

Summary

Timeline

Publications

Drugs

Indications